#ASCO24 Dr. Melina Marmarelis asks: are we on BEAT? Are there additive effects of immunotherapy and VEGF inhibition? The discordance between PFS and OS is not new: consider toxicity, crossover, unique mechanisms. Overall, no clear role demonstrated (yet) in unselected population.

Wonderful presentation by Michael Offin from MSK Department of Medicine Memorial Sloan Kettering Cancer Center showing day from investigator initiated trial of chemo+nivo in mesothelioma, demonstrating feasibility.

We are so proud to be part of “House of Lynn” Robin Zon, MD, FACP, FASCO @ASCO #ASCO24
Grateful to have fantastic leadership in the house Angie DeMichele, MD, MSCE, FASCO Penn Medicine - Abramson Cancer Center Penn Medicine Penn Medicine MD OncoAlert Penn Cancer Innovation

ADRIATIC. A brilliant presentation by David R. Spigel, MD, FASCO and discussion by Lauren Averett Byers, MD. I really reflected on the comment about despite similar HR’s, the absolute extensions are massive in LSvES. BTOG #ASCO24

The new standard of care is consolidation immunotherapy for limited stage small cell lung cancer & the first systemic therapy advance for limited small cell in ~50yrs. Allied to Laura we had fun on the ASCO non-metastatic NSCLC/SCLC/meso track committee this year! #lcsm #ASCO24

Exciting times ahead for #sclc ! But today is a pretty good start #adriatic #ASCO24 Lauren Averett Byers, MD #lcsm

Very impressive work by Helena- especially as an IIT study- great effort in a key but poorly studied subset
My #lcsm friends- Yu all should check this out!

The best part of ASCO #ASCO24 is hanging with my Penn Medicine - Abramson Cancer Center Penn Medicine Penn Medicine MD team
Lova Sun Melina Marmarelis Angie DeMichele, MD, MSCE, FASCO ASCOPres Ravi B. Parikh Steven Brem
Penn Cancer Innovation #PennPeeps

Congratulations to our @penncancer stars who will no doubt change the world and help so many patients. We are so proud and thrilled for you!
@pennmedicine
#ASCO24
Conquer Cancer, the ASCO Foundation

So proud of ⁦MGH Thoracic Oncology⁩ colleague ⁦JessicaJLinMD⁩ for her nuanced, eloquent and inspiring discussion at #ASCO24 lung oral session, reviewing data from ⁦Ben Solomon⁩ Natasha Leighl and Enriqueta Felipe. Great job Jess!

Thrilled that we have our Penn Cancer Innovation team here ASCO #ASCO24 - Anthony Martella is leading the charge on iNUDGE - improving molecular testing using behavioral economics informed nudges
Penn Medicine - Abramson Cancer Center Penn Medicine MD Penn Medicine #AI #Nudges

ICYMI from our newsletter highlighting patient & clinician directed #nudges : Nudging providers to order molecular testing for pts newly diagnosed w/ Non Small-Cell #LungCancer .

Led by PC3I's Charu Aggarwal, MD, MPH, FASCO & Melina Marmarelis
Collaboration w/ Loxo@Lilly Oncology Medical
pc3i.upenn.edu/projects/nudgi…

Ooh, love the title “Are we on BEAT” discussed by Melina Marmarelis ! This will be a great session #ASCO24

Getting two plenaries from one track (early stage NSCLC /meso/ sclc) and 3 plenaries in Lung Ca !!! Super thrilled to have been part of the track that might have just created history !!! Patrick Forde Shankar Siva Melina Marmarelis Lecia Sequist, MD, MPH Robin Zon, MD, FACP, FASCO Angie DeMichele, MD, MSCE, FASCO

THREE lung plenaries!!! …and some extremely talented and rad discussants! Lecia Sequist, MD, MPH Lauren Averett Byers, MD #lcsm

Great to see lung cancer research highly represented at the ASCO plenary session. This has been a long time coming!
#LCSM Winship Cancer Institute of Emory University.

Bravo! 🇬🇷

#TexasLung24 Melina Marmarelis Penn Medicine - Abramson Cancer Center finds inspiration in the music of Leonard Bernstein (who died of mesothelioma) to give a great review of the role of surgery (MARS), immunotherapy, Vegf inhibition in #pleuralmesothelioma Mesothelioma Applied Research Foundation @iaslc #lcsm

🔥 The ever hot debate of life after MARS2 continues at #TexasLung24

❔Patient selection
❔Role of immunotherapy

Dr. Melina Marmarelis conducts us through treatment strategies for mesothelioma at #TexasLung24 . Histology helps to guide therapy. TEADi promising. Hope to see innovation in this devastating disease.